Clinical trials
Phase 3 Schizophrenia trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 |
| Boehringer Ingelheim | 2 |
| H. Lundbeck A/S | 2 |
| Hoffmann-La Roche | 2 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Janssen-Cilag International NV | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Solvay Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 18 |
| Psychotic Disorders | 3 |
| Body Weight Changes | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.